Upneeq® is a recently approved ophthalmic application of (oxymetazoline hydrochloride
ophthalmic solution), 0.1% for the treatment of ptosis. The compound is well known in the medical industry by the trade name Afrin®.
Afrin® is not designed for or indicated for administration by the ophthalmic route.